Two single arm trials of AKL-T01, a digital therapeutic for adolescents and adults with ADHD
{{output}}
Inattention symptoms represent a key driver of functional impairment in ADHD and often persist into adolescence and adulthood, underscoring a need for novel treatments targeting attentional control. We evaluated AKL-T01-a digital therapeutic that is FDA-cleare... ...
